[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].

A L Kungurtseva, A V Popovich, Y V Tikhonovich, A V Vitebskaya
{"title":"[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].","authors":"A L Kungurtseva, A V Popovich, Y V Tikhonovich, A V Vitebskaya","doi":"10.14341/probl13369","DOIUrl":null,"url":null,"abstract":"<p><p>Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) is an ultra-orphan disease from the group of premature aging syndromes with an autosomal recessive type of inheritance associated with mutations in the POLR3A, POLR3B, and POLR3GL genes encoding RNA polymerase III. The incidence of the disease is currently unknown. We present the first clinical description in Russian Federation of a patient 7 years 6 months old with Wiedemann-Rautenstrauch syndrome (compound heterozygous mutations in POLR3A gene) with progeroid features, adentia, growth retardation (height SDS -3,41, height velocity SDS -2,47), underweight (BMI SDS -6,20), and generalized lipodystrophy. The article presents the observation of the patient for 1.5 years, the world experience of dynamic follow-up of patients with neonatal progeroid syndrome, differential diagnosis, as well as recommendations for the management of patients with this syndrome. Given the lack of specific treatment to date, patients are observed by a multidisciplinary team of physicians.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11145571/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy endokrinologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/probl13369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) is an ultra-orphan disease from the group of premature aging syndromes with an autosomal recessive type of inheritance associated with mutations in the POLR3A, POLR3B, and POLR3GL genes encoding RNA polymerase III. The incidence of the disease is currently unknown. We present the first clinical description in Russian Federation of a patient 7 years 6 months old with Wiedemann-Rautenstrauch syndrome (compound heterozygous mutations in POLR3A gene) with progeroid features, adentia, growth retardation (height SDS -3,41, height velocity SDS -2,47), underweight (BMI SDS -6,20), and generalized lipodystrophy. The article presents the observation of the patient for 1.5 years, the world experience of dynamic follow-up of patients with neonatal progeroid syndrome, differential diagnosis, as well as recommendations for the management of patients with this syndrome. Given the lack of specific treatment to date, patients are observed by a multidisciplinary team of physicians.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Wiedemann-Rautenstrauch 综合征。俄罗斯联邦首例临床病例描述]。
Wiedemann-Rautenstrauch 综合征(新生儿早衰综合征)是早衰综合征中的一种超常染色体隐性遗传病,与编码 RNA 聚合酶 III 的 POLR3A、POLR3B 和 POLR3GL 基因突变有关。该病的发病率目前尚不清楚。我们在俄罗斯联邦首次临床描述了一名 7 岁 6 个月大的维德曼-劳滕斯特劳赫综合征患者(POLR3A 基因复合杂合突变),该患者具有类早衰特征、痴呆、生长迟缓(身高 SDS -3,41,身高速度 SDS -2,47)、体重不足(体重指数 SDS -6,20)和全身脂肪营养不良。文章介绍了对该患者 1.5 年的观察情况、对新生儿类早衰综合征患者进行动态随访的世界经验、鉴别诊断以及对该综合征患者的治疗建议。鉴于迄今为止尚无特效治疗方法,患者将由一个多学科医生团队进行观察。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Cognitive impairment in patients with obesity and impaired carbohydrate metabolism (dysglycemia)]. [Features of the relationship of intestinal microbiota indicators with clinical and biochemical parameters in obese young people]. [Features of true gynecomastia in adult males]. [Polycystic ovary syndrome: new and promising treatment methods]. [Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1